Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. JOC. 2006;5(1). Accessed December 7, 2025. https://carcinogenesis.com/index.php/JOC/article/view/227